Sun, Sep 14, 2014, 11:16 PM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

EnteroMedics Inc. Message Board

adeiflig 376 posts  |  Last Activity: 8 hours ago Member since: May 2, 1999
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • I will through an idea for discussion. It is obvious that oozhee22 was pumping OREX and thrashing ETRM. Everyone was looking for a motive. I think I have found one. Here goes.

    An institution or a few wealthy people decided that they have an idea for a great payoff. They will play two stocks against each other. The play goes as follows. You short ETRM to get funds and, then you load up on OREX.

    The investor is sold on the idea that OREX is safe, effective and will be approved easily without restrictions and they will easily double or triple their money. The approval period is earlier than that of ETRM so then they sell OREX and cover their short position in ETRM, at a huge profit costing them nothing in terms of capital invested.

    This whole strategy has now backfired. The people are seeing their long position in OREX plunge on FDA approval and, not ETRM is starting to rally on their short position. This is the worst of all worlds for them. Oozhee22 has failed miserably as in between guy to make sure that this scenario plays out.

    These investors will now suffer HUGE LOSSES, as they sell OREX at a loss and, now must buy ETRM at a loss too on their short position. Only problem is that they hold huge long positions and short positions, how are they going to get out of both?

    Isn't DIVINE JUSTICE beautiful!!!! Karma....

    They can't say they were not warned....


  • Notice that the last post of oozhee22 was on September 10, 2014, one day before OREX approval and he has gone silent with no one single post.

    You can easily make the connection between OREX and ETRM.

    All the words spoken by oozhee22 happened to OREX, labeling restrictions of 46 pages, restrictions on sales period of 12 weeks, very expensive post trials and, limited revenue opportunity.

    Talk about KARMA, Orex through oozhee22 got everything they had cursed ETRM with. Now their head is in between their legs.

    Justice is beautiful to watch.


  • Isn`t Karma wonderful justice, for the words we speak come to judge us. Oozhee22 has disappeared since OREX approval which shows that he was tied to their interests of OREX. Oozhee22 wanted so badly that ETRM have restrictions that he succeeded in getting black label box for OREX of 46 pages plus limiting trial to only 12 weeks and to be discontinued if ineffective. Orex at best is worth maybe $ 1 but even that is too expensive. Realistic sales with all these restrictions are going to be $ 2 million per quarter or less at most.

    Divine law of Justice: be nice to everyone and considerate of their investment, don`t lie or cheat, be honourable and God will give you your reward with time.


  • Your choice: stay in ARNA or watch 1500% return develop in ETRM: approval soon.


  • Your choice, see OREX continue its plunge to $ 2 or watch ETRM soar 1500% to $ 15, approval soon.


  • adeiflig by adeiflig Sep 12, 2014 9:04 AM Flag

    Investors do not realize that VBLOC will have a monopoly in an unmet need. Those who refuse pills and do not want bariartic surgery will all go to VBLOC as there is nothing in between these two solutions for obesity.

    Both alternatives have been rejected by the market and explains why obesity rates are soaring. At best pill companies are making $ 5 million per quarter which hardly puts a dent into obesity. Adding more pills to the market will not solve anything, most people can't take the pill since they have a host of other related health issues. In essence a pill simply does not make you lose weight without causing you harm. Doctors know this and refuse to prescribe. Imagine that ARNA has a 900 people sales force, VVUS half of this and OREX will be bigger than ARNA and they are going no where.

    With bariatric surgery you have 20 million patients who are eligible now and only 300,000 choose surgery which is 1.5% of patients, again measily rates which do nothing for obesity.

    Hence we have VBLOC which will give market what it wants. It is SAFE, it is reversible, it does not change eating habits, it gives you flexibility of use, you get to keep your organs, and there NO DEATH rates. This is s serious threat to competitors whom will see patients flock to the device and explains why posters like oozhee22 with no position come bashing, bashing, bashing.... If VBLOC was #$# then no need to bash.


  • I have a long position six (6) digit figure in shares, having first purchased in September 2013. I have not sold one (1) single share, being as loyal and committed to my position as possible. It is either you believe in your decision or you don't. I am not oozhee22 and have no association with him. I think personally he is an evil person whom was paid off in some form to push Orex and knock down ETRM. I am so happy that karma exists and that OREX plunged, serves him right. It is just the beginning of the plunge.

    That being said, I will repeat what I have seen in the stock market over the years. The market knows zippo or nothing on investing. It trades on emotions of fear and greed, it reacts and does not anticipate at all. It has no brains, just like a monkey at a casino. I had CSIQ which was trading at $ 3.50 and I saw value in to $ 24, while others did not. Market caught up and it went to $ 45. Dndn at $ 3, market caught up all the way to $55. Kndi at $ 3, market caught up now at $ 16. Kerx at $ 4, market caught up now at $ 18. ISRG at $ 80, market caught up now at $ 400. FB at $ 19, market caught up now at $ 75. The list goes on and on and on.

    We all look at ETRM valued at measily $ 85 million, about to get VBLOC approval to launch in multi billion market with buyout possiblities. You can't understand why so cheap and figure you may be wrong. Think are RIGHT except timing is a bit early, that is all. I saw this opportunity in September 2013, perhaps market will catch up in mid 2015 when price is at $ 22. Is it your fault that you can see an opportunity while others are dormant. No, it is a blessing!!!! What you should do is try to raise as much money as possible to load up as much as possible, even mortgaging your home. When price is at ridicule level that is when you go all out. When it goes to $ 50 and people say it is a gem to buy, then you better sell.


  • It will have similar reaction that VVUS did when they were 1st pill on the market; VBLOC first device on the market in 10 years.

    Or, you don`t listen to me but listen to oozhee22, he has terrific record of late. He was hoping for restrictions on VBLOC instead he got restrictions on OREX, enjoy.


  • Reply to


    by adeiflig Sep 11, 2014 9:24 AM
    adeiflig adeiflig Sep 11, 2014 11:07 AM Flag

    I agree, it is a "me too" product where two others have flopped. Arna and VVUS barely have a few million dollars in sales per quarter like $ 5 million. That is hardly blockbuster yet they carry blockbuster market prices.

    The shift will occur soon as investors of pills will begin to flock to medical device of VBLOC which is revolutionary and will be the 1st to be approved in 10 years. It will have the same impact as VVUS which was 1st on market, soaring from $ 1 to $ 15 overnight.

    The fact that OREX has so much restriction in already a market that has voted down pills is a bad sign hence selloff for them and it will continue for the next month to hit new lows. OREX should carry a valuation of no more than $ 100 million. They feared VBLOC so much that they most likely hired oozhee22.


  • Reply to


    by adeiflig Sep 11, 2014 9:24 AM
    adeiflig adeiflig Sep 11, 2014 10:05 AM Flag

    It is PLUNGING; FDA approved but they might as well have said NOT APPROVED with the mountain of restrictions on it, including dire warnings on black label. Needs to go down to the $ 3 level and then still too expensive.

    This is yet another black eye for oozhee22....

    Do you love his analysis?


  • Not safe at all. It does nothing to reduce heart attacks, strokes or other possible benefits. As a matter of fact it carries more risk than others.

    VBLOC is totally safe compared to bariartic surgery of 1 death per 300 candidates and, benefits both hypertension and diebetic, two other huge markets.

    It is clear that pills don't sell and explains why competition is hostile towards VBLOC. Adding a third pill to the market of a different color from ARNA, VVUS will not do much. People want safefy and black box scares the wits out of people.


  • Reply to

    New York Times

    by innsbrooklad Sep 10, 2014 10:15 PM
    adeiflig adeiflig Sep 10, 2014 10:23 PM Flag

    I agree. Doctors first look out for their own self-interest and that is not to get sued. Secondly fat people have a host of medical issues already, add a dangerous pill and you might as well refer them to a funeral home.

    I see pop on Orex and then selloff or, just selloff right away due to black box labelling plus 12 week restriction.


  • adeiflig adeiflig Sep 10, 2014 10:21 PM Flag

    Don't forget to add the funeral expenses plus a long line of medical lawsuits requiring lawyer fees plus traumautized doctors who go bankrupt due to dangerous side effects....

    If Doctors are not approving a safer ARNA pill, they will run from OREX pill.

    If they sell 2 pills per year I would be surprised.


  • Reply to

    Orex approved with such SEVERE SIDE EFFECTS...

    by adeiflig Sep 10, 2014 7:22 PM
    adeiflig adeiflig Sep 10, 2014 7:26 PM Flag

    One death from this pill and, pill market is FINISHED.

  • Reply to

    Orex approved with such SEVERE SIDE EFFECTS...

    by adeiflig Sep 10, 2014 7:22 PM
    adeiflig adeiflig Sep 10, 2014 7:24 PM Flag

    Who the heck would take this pill? Compare that with VBLOC with is about as safe as you can get. People WANT safety and these suicidal pills ain't going to do the job.

    This tells us that FDA really needs solutions and VBLOC will easily be approved compared to this dangerous pill.


  • No one will be taking their pill which such severe side effects, black box warning and to be discontinued at 12 weeks if not more than 5% of weight is lost.

    Here are side effects:

    Patients using Contrave at the maintenance dose should be evaluated after 12 weeks to determine if the treatment is working. If a patient has not lost at least 5 percent of baseline body weight, Contrave should be discontinued, as it is unlikely that the patient will achieve and sustain clinically meaningful weight loss with continued treatment.

    Because it contains bupropion, Contrave has a boxed warning to alert health care professionals and patients to the increased risk of suicidal thoughts and behaviors associated with antidepressant drugs. The warning also notes that serious neuropsychiatric events have been reported in patients taking bupropion for smoking cessation.

    Contrave can cause seizures and must not be used in patients who have seizure disorders. The risk of seizure is dose-related. Contrave should be discontinued and not restarted in patients who experience a seizure while being treated with Contrave.

    Contrave can also raise blood pressure and heart rate and must not be used in patients with uncontrolled high blood pressure. The clinical significance of the increases in blood pressure and heart rate observed with Contrave treatment is unclear, especially for patients with heart-related and cerebrovascular (blood vessel dysfunction impacting the brain) disease, since patients with a history of heart attack or stroke in the previous six months, life-threatening arrhythmias, or congestive heart failure were excluded from the clinical trials. Blood pressure and pulse should be measured prior to starting the drug and should be monitored at regular intervals, particularly among patients with controlled high blood pressure prior to treatment.

    Other products containing bupropion should not be taken along with Contrave. The drug should not be used in patients who have eating disorders (bulimia or anorexia nervosa). Contrave should also not be taken by patients who are using opioids or treatments for opioid dependence, or who are experiencing acute opiate withdrawal. Patients undergoing an abrupt discontinuation of alcohol, benzodiazepines, barbiturates and antiepileptic drugs should not take Contrave. Women who are pregnant or trying to become pregnant should not take Contrave.

  • That would be nice.....


  • Reply to


    by sguceri Sep 9, 2014 9:14 PM
    adeiflig adeiflig Sep 10, 2014 9:09 AM Flag

    I think he sold and moved on. So much for guts.


  • adeiflig adeiflig Sep 10, 2014 9:09 AM Flag

    I heard that OREX will have FDA decision and, they are either going to REJECT or put strong labeling on pills as to be available only to monkeys since human trials was too risky.


  • Reply to

    Approval is imminent, within days at most (vision)

    by adeiflig Sep 9, 2014 12:11 PM
    adeiflig adeiflig Sep 9, 2014 12:24 PM Flag

    I hope you are right, that vision scared the heck out of me.

    Hopefully, it is the reverse, going to $ 20.


1.31+0.07(+5.65%)Sep 12 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
21Vianet Group, Inc.
NasdaqGSFri, Sep 12, 2014 4:00 PM EDT
Darden Restaurants, Inc.
NYSEFri, Sep 12, 2014 4:03 PM EDT